Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126359722 | 12635972 | 2 | F | 2016 | 20160806 | 20160809 | 20160812 | EXP | US-PFIZER INC-2016377633 | PFIZER | 49.00 | YR | F | Y | 0.00000 | 20160812 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126359722 | 12635972 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | UNK | U | 21992 | PROLONGED-RELEASE TABLET | ||||||||
| 126359722 | 12635972 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, 1X/DAY, AT NIGHT | U | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | |||||
| 126359722 | 12635972 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG (CUTS 100MG INTO HALF), 1X/DAY | U | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | |||||
| 126359722 | 12635972 | 4 | C | VIIBRYD | VILAZODONE HYDROCHLORIDE | 1 | 40 MG, UNK | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126359722 | 12635972 | 1 | Depression |
| 126359722 | 12635972 | 2 | Serum serotonin decreased |
| 126359722 | 12635972 | 4 | Serum serotonin decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126359722 | 12635972 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126359722 | 12635972 | Anxiety | |
| 126359722 | 12635972 | Constipation | |
| 126359722 | 12635972 | Drug ineffective | |
| 126359722 | 12635972 | Hallucination | |
| 126359722 | 12635972 | Hyperhidrosis | |
| 126359722 | 12635972 | Intentional product misuse | |
| 126359722 | 12635972 | Malaise | |
| 126359722 | 12635972 | Medication residue present | |
| 126359722 | 12635972 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126359722 | 12635972 | 1 | 201605 | 2016 | 0 | |
| 126359722 | 12635972 | 2 | 2016 | 2016 | 0 | |
| 126359722 | 12635972 | 3 | 2016 | 0 |